Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4561)
All Articles published online
|
Publishing Process of This Article
|
Aug 14, 2022 (publication date) through May 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chen WD, Zhang X, Zhang MJ, Zhang YP, Shang ZQ, Xin YW, Zhang Y. Salivary Fusobacterium nucleatum serves as a potential diagnostic biomarker for gastric cancer. World J Gastroenterol 2022; 28(30): 4120-4132 [PMID: 36157109 DOI: 10.3748/wjg.v28.i30.4120] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v28/i30/4120.htm |
| Number | Citing Articles |
| 1 |
Mengjiao Zhang, Yifeng Wang, Longchen Yu, Yanli Zhang, Yanlei Wang, Ziqi Shang, Yiwei Xin, Xinyang Li, Nannan Ning, Yi Zhang, Xin Zhang. Fusobacterium nucleatum promotes colorectal cancer metastasis by excretion of miR-122-5p from cells via exosomes. iScience 2023; 26(9): 107686 doi: 10.1016/j.isci.2023.107686
|
| 2 |
Eri Komori, Nahoko Kato-Kogoe, Yoshiro Imai, Shoichi Sakaguchi, Kohei Taniguchi, Michi Omori, Mayu Ohmichi, Shota Nakamura, Takashi Nakano, Sang-Woong Lee, Takaaki Ueno. Changes in salivary microbiota due to gastric cancer resection and its relation to gastric fluid microbiota. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-43108-8
|
| 3 |
Xiangkun Meng, Gang Ma, Xu Zhang, Hua Yin, Yu Miao, Fang He.
Extracellular vesicles from
Fusobacterium nucleatum
: roles in the malignant phenotypes of gastric cancer
. Cell Cycle 2024; 23(3): 294 doi: 10.1080/15384101.2024.2324587
|
| 4 |
Xi Yin Yang, Kaifeng Zhu, Qiang Hu. The order of surgery and chemotherapy matters: Multimodality therapy and stage‐specific differences in survival in gastric cancer. Journal of Surgical Oncology 2023; 127(3): 517 doi: 10.1002/jso.27158
|
| 5 |
Yiwei Xin, Xinyang Li, Mengjiao Zhang, Ziqi Shang, Zhengdong Luo, Yifeng Wang, Xinru Gui, Qi Liu, Tingting Li, Shunjie Zeng, Helgi B. Schiöth, Xin Zhang, Yi Zhang. Fusobacterium nucleatum‐induced exosomal HOTTIP promotes gastric cancer progression through the microRNA‐885‐3p/EphB2 axis. Cancer Science 2023; 114(6): 2360 doi: 10.1111/cas.15781
|
| 6 |
Sara Tharwat Abdullah, Snur Rasool Abdullah, Bashdar Mahmud Hussen, Yousif Mohammed Younis, Mohammed Fatih Rasul, Mohammad Taheri. Role of circular RNAs and gut microbiome in gastrointestinal cancers and therapeutic targets. Non-coding RNA Research 2024; 9(1): 236 doi: 10.1016/j.ncrna.2023.12.002
|
| 7 |
Songhe Guo, Fangfang Chen, Linfang Li, Shuheng Dou, Qifan Li, Yuying Huang, Zijun Li, Wanli Liu, Ge Zhang. Intracellular Fusobacterium nucleatum infection increases METTL3-mediated m6A methylation to promote the metastasis of esophageal squamous cell carcinoma. Journal of Advanced Research 2023; doi: 10.1016/j.jare.2023.08.014
|
| 8 |
Amani M. Harrandah. The role of Fusobacteria in oral cancer and immune evasion. Current Opinion in Oncology 2023; 35(2): 125 doi: 10.1097/CCO.0000000000000927
|
| 9 |
Alexa Little, Mark Tangney, Michael M. Tunney, Niamh E. Buckley. Fusobacterium nucleatum: a novel immune modulator in breast cancer?. Expert Reviews in Molecular Medicine 2023; 25 doi: 10.1017/erm.2023.9
|
| 10 |
Sadaf Wajahat. Role of microorganisms in the developmental, prognostic, and therapeutics of gastric cancer. Iranian Journal of Blood and Cancer 2023; 15(4): 272 doi: 10.61186/ijbc.15.4.272
|
| 11 |
Chun Ye, Xiao Liu, Zilun Liu, Chuxuan Pan, Xiaowei Zhang, Zhanyi Zhao, Haitao Sun. Fusobacterium nucleatum in tumors: from tumorigenesis to tumor metastasis and tumor resistance. Cancer Biology & Therapy 2024; 25(1) doi: 10.1080/15384047.2024.2306676
|